Adarza BioSystems

Founded in 2008, Adarza has developed a highly sensitive label-free diagnostic platform capable of measuring 100s more individual proteins than the best multiplex immunoassays available today. The Arrayed Imaging Reflectometry (AIR™) is a label-free platform technology that enables the simultaneous detection of hundreds of analytes in a single drop of fluid. Adarza delivers industry leading precision, accuracy, and robustness enabling highly multiplexed protein detection with high sensitivity and specificity. The company’s unique technology is flexible, data-rich, and easy to use, providing the only solution that spans the entire companion diagnostic life cycle from discovery to clinic, in both high-throughput core facilities as well as point of care (POC). Much like the first gene-chips enabled multiplexed genomics analysis, Adarza’s first-to-market high-multiplex and sensitivity antibody chips will fundamentally disrupt the field of proteomics research. Adarza is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at University of Rochester by Dr. Benjamin Miller, Adarza’s scientific founder.
Type
Private
HQ
West Henrietta, US
Founded
2008
Employees
12 (est)
Adarza BioSystems was founded in 2008 and is headquartered in West Henrietta, US

Adarza BioSystems Locations

West Henrietta, US
Saint Peters, US

Adarza BioSystems Metrics

Adarza BioSystems Summary

Founding Date

2008

Total Funding

$14.1 M

Latest funding size

$5 M

Time since last funding

9 months

Investors

Adarza BioSystems's latest funding round of $5 M was in March 2016. In total, Adarza BioSystems has raised $14.1 M.

Adarza BioSystems Company Life

You may also be interested in